Noxalk 150 mg Capsules (Ceritinib 150 mg)

Noxalk 150 mg Capsule is an oral tyrosine kinase inhibitor (TKI) developed for patients with ALK gene mutation-positive lung cancer. It is specifically used in advanced or metastatic non-small cell lung cancer (NSCLC) where abnormal ALK protein activity drives cancer cell growth.

This medicine is part of precision oncology therapy, targeting cancer at the molecular level rather than damaging healthy cells like traditional chemotherapy.

Uses of Noxalk 150 mg Capsule

Noxalk 150 mg is used in the treatment of:

• ALK-positive Non-Small Cell Lung Cancer (NSCLC)

• Advanced lung cancer with ALK gene rearrangement

• Metastatic lung cancer

• Progressive lung cancer after other therapies

How Noxalk (Ceritinib) Works

Ceritinib works by:

• Inhibiting ALK (Anaplastic Lymphoma Kinase) protein

• Blocking cancer cell signaling pathways

• Preventing cancer cell multiplication

• Stopping tumor growth and spread

• Inducing cancer cell death (apoptosis)

This targeted mechanism makes it more effective and selective than conventional chemotherapy.

Dosage & Administration

• Taken orally as prescribed by the oncologist

• Usually taken once daily

• Dose depends on patient condition and tolerance

• Should be taken at the same time every day

• Do not crush or open the capsule

⚠️ Only to be used under oncologist supervision

Benefits of Noxalk 150 mg Capsule

• Targeted therapy for ALK-positive lung cancer

• Slows disease progression

• Improves survival outcomes

• Oral administration (no hospitalization required)

• Precision medicine with molecular targeting

• Better quality of life compared to chemotherapy

Possible Side Effects

Common side effects include:

• Nausea and vomiting

• Diarrhea

• Abdominal pain

• Fatigue

• Decreased appetite

• Liver enzyme elevation

• Headache

• Dizziness

Serious side effects may include:

• Liver toxicity

• Lung inflammation (pneumonitis)

• Heart rhythm problems (QT prolongation)

• Severe gastrointestinal toxicity

Precautions & Warnings

• Use only under specialist supervision

• Regular liver function monitoring required

• ECG monitoring may be needed

• Avoid pregnancy and breastfeeding

• Inform doctor about liver, heart, or lung conditions

• Avoid grapefruit and grapefruit juice

• Not for pediatric use unless prescribed

Drug Interactions

Noxalk may interact with:

• Antifungal medicines

• Antibiotics

• Anti-epileptic drugs

• Heart rhythm medicines

• HIV medications

Always share full medication history with your doctor.

Storage Instructions

• Store below 25°C

• Protect from moisture and sunlight

• Keep in original packaging

• Keep out of reach of children

Why Choose Noxalk 150 mg Capsule?

• Manufactured by Natco Pharma Ltd (trusted oncology manufacturer)

• Proven efficacy in ALK-positive NSCLC

• Cost-effective alternative to imported brands

• Precision targeted therapy

• Widely used in oncology protocols

• Oral targeted cancer treatment

FAQs – Noxalk 150 mg Capsule

Q1. What cancer is Noxalk used for?
It is used for ALK-positive non-small cell lung cancer (NSCLC).

Q2. Is Noxalk chemotherapy?
No, it is a targeted therapy, not chemotherapy.

Q3. Does it cure lung cancer?
It does not cure but helps control disease progression and improve survival.

Q4. Is genetic testing required?
Yes, ALK mutation testing is required before starting therapy.

Q5. Can it be taken long-term?
Yes, as long as the patient is responding and tolerating treatment.